Shan Su | Oncology | Best Researcher Award Posted on 08/11/202411/11/2024 by sciencefatherLeave a Comment on Shan Su | Oncology | Best Researcher Award Dr. Shan Su | Oncology | Best Researcher Award Professional Memberships: Her membership with the International Association for the Study of Lung Cancer (IASLC) indicates her active participation in the global oncology research community, further enhancing her profile as a top researcher. Dr. Shan Su ,Guangzhou Chest Hospital, China Profile Scopus OrcID 🌱EARLY ACADEMIC PURSUITS Shan Su began her academic journey with a strong focus on clinical oncology, immersing herself in the study of treatment methodologies and therapies for various types of cancer, especially lung cancer. Early in her career, her dedication to patient-centered treatment approaches led her to explore a range of therapeutic practices, including chemotherapy, targeted therapies, and immunotherapy. 💼 PROFESSIONAL ENDEAVORS As the Chief Physician at Guangzhou Chest Hospital, Shan Su has taken on a prominent role in the field of oncology, specializing in advanced and innovative cancer treatments. Over her ten-year tenure, she has applied targeted therapy, immunotherapy, and even local microwave ablation to treat malignant tumors, focusing particularly on lung tumors. Her role involves not only treating patients but also leading clinical advancements and educating the next generation of oncology professionals. 🔬CONTRIBUTIONS AND RESEARCH FOCUS Dr. Su’s research has paved the way in studying complex interactions between malignancies and other diseases, notably tuberculosis (TB). Recognizing a gap in the understanding of cancer patients with concurrent TB, she led a pioneering cohort study—the largest of its kind worldwide—documenting unique treatment challenges and outcomes. Currently, she is spearheading the first international clinical study investigating the effects of combining first-line chemotherapy with immunotherapy for lung cancer patients who have active pulmonary TB, with a primary focus on evaluating the safety and efficacy of these combined treatments. 📚ACADEMIC CITES Throughout her career, Dr. Su’s research has been recognized and cited by numerous peers in the medical community, underscoring her contributions to oncology and her influence on cancer research. Her work in combining immunotherapy with chemotherapy for complex cases is particularly well-regarded, with citations reflecting the growing interest and importance of her findings. 🌍IMPACT AND INFLUENCE Dr. Su’s work has influenced clinical practices on a global scale. Her expertise has contributed significantly to the understanding of complex cases involving co-occurring cancer and TB, impacting treatment protocols and inspiring other researchers to explore similar areas. As a member of the International Association for the Study of Lung Cancer (IASLC), she collaborates with a network of global oncology professionals to advance knowledge and share insights into lung cancer treatment. 🌟LEGACY AND FUTURE AND CONTRIBUTIONS Looking forward, Dr. Su remains committed to advancing oncological treatments, especially for complex cases like cancer with tuberculosis. Her ongoing research projects hold great promise for improving patient outcomes and expanding treatment options, making her a pioneer in her field. Dr. Su’s legacy will likely include groundbreaking contributions to cancer therapy innovations, laying the foundation for future treatments and offering hope for patients worldwide. 📄Publications The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study Authors: Li, L., Zhang, H., Xie, Y., Cen, W., Koundal, D. Journal: Computational and Mathematical Methods in Medicine, 2022, 2022, 1475871 Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage Authors: Su, S., Ye, M.-F., Cai, X.-T., Huang, H.-Y., Dong, Z.-Y. Journal: BMC Medicine, 2021, 19(1), 322 Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival Authors: Chen, R.-L., Zhou, J.-X., Cao, Y., Wang, S.-Y., Lin, L.-Z. Journal: Frontiers in Immunology, 2020, 11, 1933 Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing Authors: Su, S., Zou, J.-J., Zeng, Y.-Y., Zhao, Z.-G., Liu, J.-X. Journal: BioMed Research International, 2019, 2019, 6096350 Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy Authors: Zou, J., Su, S., Chen, Z., Xia, Y., Huang, D. Journal: Artificial Cells, Nanomedicine and Biotechnology, 2019, 47(1), pp. 3456–3464
Ben Wang | Oncology | Best Researcher Award Posted on 20/09/202423/09/2024 by sciencefatherLeave a Comment on Ben Wang | Oncology | Best Researcher Award Prof . Ben Wang | Oncology | Best Researcher Award Recognition and Awards: Dr. Wang has received numerous awards throughout his career, including recognition from the National Science Foundation and various engineering societies. These accolades highlight his consistent contributions to advancing material science. Prof. Ben Wang , Zhejiang University , China Profile Scopus OrcID Google Scholar 🎓Early Academic Pursuits Dr. Wang Ben was born in June 1983 in Qufu, China. His academic journey began with a Bachelor of Science in Chemical Engineering at Qufu Normal University in 2004. He then pursued his Master’s in Biology at Zhejiang University, focusing on the secondary metabolism of endophytic fungi from antitumor plants. His academic excellence earned him a Ph.D. in Chemistry & Biomedical Engineering from Zhejiang University in collaboration with Harvard University in 2011, under the guidance of Prof. Ruikang Tang and Prof. Ali Khademhosseini. His doctoral research focused on cellular shellization and surface engineering for single-cell modification and protection. 💼Professional Endeavors Dr. Wang Ben’s career has been defined by his contributions to cancer metabolism and biomedical engineering. After completing his postdoctoral work at Zhejiang University in 2013, he served as an Associate Professor and Qiushi Young Scholar until 2022, when he was promoted to Professor. His work as Dean Assistant at the Institute of Translational Medicine and Deputy Director of the Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism showcases his leadership and contributions to the academic community. He also serves as a PI at the Cancer Institute of The Second Affiliated Hospital of Zhejiang University. 🔬 CONTRIBUTIONS AND RESEARCH FOCUS Dr. Wang’s research primarily revolves around cancer metabolism, cellular engineering, and biomedical innovations. His innovative research in translational medicine seeks to bridge laboratory research with practical clinical applications. Key areas of his research include: Surface engineering for single-cell modification Metabolism-related cancer research Advancements in transvascular implantation devices Dr. Wang has also played a critical role as a panel judge for the National Natural Science Foundation of China and has been actively involved in several international research collaborations, contributing to a wide range of scientific publications. 🌍Impact and Influence Dr. Wang’s impact extends beyond research, with significant contributions to education and mentorship. He has undertaken extensive teaching responsibilities, from undergraduate biology courses to graduate thesis guidance, impacting hundreds of students. His mentorship has produced many successful Ph.D. and master’s candidates who have gone on to establish themselves in academia and industry.As a journal reviewer for numerous prestigious scientific publications, including ACS Nano, Advanced Materials, and Biomaterials, Dr. Wang has helped shape the discourse in chemistry, biology, and biomedical engineering fields. His expertise is highly sought after by journals such as Chemical Science and Journal of Controlled Release. 🏅ACADEMIC CITES Dr. Wang Ben’s research is widely recognized within the academic community, reflected in his growing number of citations. His Google Scholar profile shows a robust citation record, underscoring the influence of his research in both cancer metabolism and biomedical engineering fields. 📚LEGACY AND FUTURE CONTRIBUTIONS Dr. Wang’s legacy in the field of cancer metabolism and transvascular implantation devices continues to grow. His future work promises to contribute further to cancer treatment, aiming to integrate innovative biomedical solutions into mainstream healthcare. His leadership roles and international collaborations highlight his dedication to driving forward impactful translational medical research. 📰PUBLICATIONS Acid-base transformative HADLA micelles alleviate colitis by restoring adaptive immunity and gut microbiome Authors: Cheng, W.; Zhou, X.; Jin, C.; Ji, F.; Wang, B. Journal: Journal of Controlled Release, 2023, Volume 364, Pages 283–296. Targeted glycan degradation potentiates cellular immunotherapy for solid tumors Authors: Wu, J.; Wang, X.; Huang, Y.; Zhang, J.; Wang, B. Journal: Proceedings of the National Academy of Sciences of the United States of America, 2023, Volume 120(38), Article e2300366120. A GSTP1-mediated lactic acid signaling promotes tumorigenesis through the PPP oxidative branch Authors: Sun, Y.; He, Q.; Li, J.; Luo, H.; Luo, Y. Journal: Cell Death and Disease, 2023, Volume 14(7), Article 463. Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD Authors: Zhang, Y.; Wu, J.; An, Q.; Wang, B.; Lin, W. Journal: Nano Research, 2023, Volume 16(7), Pages 9701–9714. Chemoimmunological Cascade Cancer Therapy Using Fluorine Assembly Nanomedicine Authors: Zhang, Q.; Wu, P.; Wu, J.; Wang, S.; Wang, B. Journal: ACS Nano, 2023, Volume 17(8), Pages 7498–7510.
Dr. Wang’s research primarily revolves around cancer metabolism, cellular engineering, and biomedical innovations. His innovative research in translational medicine seeks to bridge laboratory research with practical clinical applications. Key areas of his research include: Surface engineering for single-cell modification Metabolism-related cancer research Advancements in transvascular implantation devices Dr. Wang has also played a critical role as a panel judge for the National Natural Science Foundation of China and has been actively involved in several international research collaborations, contributing to a wide range of scientific publications.